BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 24991108)

  • 1. Luteolin, a bioflavonoid inhibits azoxymethane-induced colon carcinogenesis: Involvement of iNOS and COX-2.
    Pandurangan AK; Kumar SA; Dharmalingam P; Ganapasam S
    Pharmacogn Mag; 2014 Apr; 10(Suppl 2):S306-10. PubMed ID: 24991108
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Luteolin, a bioflavonoid, attenuates azoxymethane-induced effects on mitochondrial enzymes in BALB/c mice.
    Pandurangan AK; Ananda Sadagopan SK; Dharmalingam P; Ganapasam S
    Asian Pac J Cancer Prev; 2014 Jan; 14(11):6669-72. PubMed ID: 24377586
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Luteolin inhibits matrix metalloproteinase 9 and 2 in azoxymethane-induced colon carcinogenesis.
    Pandurangan AK; Dharmalingam P; Sadagopan SK; Ganapasam S
    Hum Exp Toxicol; 2014 Nov; 33(11):1176-85. PubMed ID: 24532706
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protective role of luteolin on the status of lipid peroxidation and antioxidant defense against azoxymethane-induced experimental colon carcinogenesis.
    Ashokkumar P; Sudhandiran G
    Biomed Pharmacother; 2008 Nov; 62(9):590-7. PubMed ID: 18692983
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of luteolin on the levels of glycoproteins during azoxymethane-induced colon carcinogenesis in mice.
    Pandurangan AK; Dharmalingam P; Ananda Sadagopan SK; Ganapasam S
    Asian Pac J Cancer Prev; 2012; 13(4):1569-73. PubMed ID: 22799368
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemopreventive properties of a selective inducible nitric oxide synthase inhibitor in colon carcinogenesis, administered alone or in combination with celecoxib, a selective cyclooxygenase-2 inhibitor.
    Rao CV; Indranie C; Simi B; Manning PT; Connor JR; Reddy BS
    Cancer Res; 2002 Jan; 62(1):165-70. PubMed ID: 11782374
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Luteolin, a bioflavonoid inhibits Azoxymethane-induced colorectal cancer through activation of Nrf2 signaling.
    Pandurangan AK; Ananda Sadagopan SK; Dharmalingam P; Ganapasam S
    Toxicol Mech Methods; 2014 Jan; 24(1):13-20. PubMed ID: 24024667
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Luteolin inhibits cell proliferation during Azoxymethane-induced experimental colon carcinogenesis via Wnt/ β-catenin pathway.
    Ashokkumar P; Sudhandiran G
    Invest New Drugs; 2011 Apr; 29(2):273-84. PubMed ID: 20013030
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pterostilbene is more potent than resveratrol in preventing azoxymethane (AOM)-induced colon tumorigenesis via activation of the NF-E2-related factor 2 (Nrf2)-mediated antioxidant signaling pathway.
    Chiou YS; Tsai ML; Nagabhushanam K; Wang YJ; Wu CH; Ho CT; Pan MH
    J Agric Food Chem; 2011 Mar; 59(6):2725-33. PubMed ID: 21355597
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preventive potential of wheat bran fractions against experimental colon carcinogenesis: implications for human colon cancer prevention.
    Reddy BS; Hirose Y; Cohen LA; Simi B; Cooma I; Rao CV
    Cancer Res; 2000 Sep; 60(17):4792-7. PubMed ID: 10987288
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hesperidin alleviates oxidative stress and downregulates the expressions of proliferative and inflammatory markers in azoxymethane-induced experimental colon carcinogenesis in mice.
    Saiprasad G; Chitra P; Manikandan R; Sudhandiran G
    Inflamm Res; 2013 Apr; 62(4):425-40. PubMed ID: 23377175
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The epigenetic effects of aspirin: the modification of histone H3 lysine 27 acetylation in the prevention of colon carcinogenesis in azoxymethane- and dextran sulfate sodium-treated CF-1 mice.
    Guo Y; Liu Y; Zhang C; Su ZY; Li W; Huang MT; Kong AN
    Carcinogenesis; 2016 Jun; 37(6):616-624. PubMed ID: 27207670
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dietary cocoa protects against colitis-associated cancer by activating the Nrf2/Keap1 pathway.
    Pandurangan AK; Saadatdoust Z; Esa NM; Hamzah H; Ismail A
    Biofactors; 2015; 41(1):1-14. PubMed ID: 25545372
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kimchi protects against azoxymethane/dextran sulfate sodium-induced colorectal carcinogenesis in mice.
    Kim HY; Song JL; Chang HK; Kang SA; Park KY
    J Med Food; 2014 Aug; 17(8):833-41. PubMed ID: 25029638
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Brewers' rice modulates oxidative stress in azoxymethane-mediated colon carcinogenesis in rats.
    Tan BL; Norhaizan ME; Huynh K; Yeap SK; Hazilawati H; Roselina K
    World J Gastroenterol; 2015 Aug; 21(29):8826-35. PubMed ID: 26269672
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pterostilbene inhibits colorectal aberrant crypt foci (ACF) and colon carcinogenesis via suppression of multiple signal transduction pathways in azoxymethane-treated mice.
    Chiou YS; Tsai ML; Wang YJ; Cheng AC; Lai WM; Badmaev V; Ho CT; Pan MH
    J Agric Food Chem; 2010 Aug; 58(15):8833-41. PubMed ID: 20681671
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Altered expression of beta-catenin, inducible nitric oxide synthase and cyclooxygenase-2 in azoxymethane-induced rat colon carcinogenesis.
    Takahashi M; Mutoh M; Kawamori T; Sugimura T; Wakabayashi K
    Carcinogenesis; 2000 Jul; 21(7):1319-27. PubMed ID: 10874009
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suppression of colitis-related mouse colon carcinogenesis by a COX-2 inhibitor and PPAR ligands.
    Kohno H; Suzuki R; Sugie S; Tanaka T
    BMC Cancer; 2005 May; 5():46. PubMed ID: 15892897
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemoprevention of colonic aberrant crypt foci by an inducible nitric oxide synthase-selective inhibitor.
    Rao CV; Kawamori T; Hamid R; Reddy BS
    Carcinogenesis; 1999 Apr; 20(4):641-4. PubMed ID: 10223193
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suppressive effect of an inducible nitric oxide inhibitor, ONO-1714, on AOM-induced rat colon carcinogenesis.
    Takahashi M; Mutoh M; Shoji Y; Sato H; Kamanaka Y; Naka M; Maruyama T; Sugimura T; Wakabayashi K
    Nitric Oxide; 2006 Mar; 14(2):130-6. PubMed ID: 16122953
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.